iSuRe-HadCre is an essential tool for effective conditional genetics
Nucleic Acids Research · 22.07.2024 · 52 (13) · e56-e56
DOI: 10.1093/nar/gkae472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 08.06.2024. Verfasst von Irene Garcia-Gonzalez und 15 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Genetics of Angiogenesis Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. Hauptthemen laut MEDLINE: Integrases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: PI R.B, Ministerio de Ciencia e Innovación, Fundacion La Caixa.
Abstract (Originalsprache)
Methods for modifying gene function at high spatiotemporal resolution in mice have revolutionized biomedical research, with Cre-loxP being the most widely used technology. However, the Cre-loxP technology has several drawbacks, including weak activity, leakiness, toxicity, and low reliability of existing Cre-reporters. This is mainly because different genes flanked by loxP sites (floxed) vary widely in their sensitivity to Cre-mediated recombination. Here, we report the generation, validation, and utility of iSuRe-HadCre, a new dual Cre-reporter and deleter mouse line that avoids these drawbacks. iSuRe-HadCre achieves this through a novel inducible dual-recombinase genetic cascade that ensures that cells expressing a fluorescent reporter had only transient Cre activity, that is nonetheless sufficient to effectively delete floxed genes. iSuRe-HadCre worked reliably in all cell types and for the 13 floxed genes tested. This new tool will enable the precise, efficient, and trustworthy analysis of gene function in entire mouse tissues or in single cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Molecular Genetics of Angiogenesis Group, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
- Uppsala University, Department of Immunology, Genetics and Pathology, Dag Hammarskjölds väg 20, 751 85 Uppsala, Sweden.
- Angiogenesis & Metabolism Laboratory, Center of Vascular Biomedicine, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
- Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
- Endothelial Pathobiology and Microenviroment Group, Josep Carreras Leukaemia Research Institute (IJC), 08916 Badalona, Barcelona, Catalonia, Spain.
- Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain.
ORCID-Profile: Sergi Roig-Soucase, Taija Makinen, Rui Benedito
Förderung
- PI R.B
- Ministerio de Ciencia e Innovación
- Fundacion La Caixa
- Knut and Alice Wallenberg Foundation
- Göran Gustafsson foundation
- Fundación La Caixa
- Swedish Society for Medical Research
- European Union's Horizon 2020
Zitieren
APA
Garcia-Gonzalez, I., Rocha, S. F., Hamidi, A., Garcia-Ortega, L., Regano, A., Sanchez-Muñoz, M. S., Lytvyn, M., Garcia-Cabero, A., Roig-Soucase, S., Schoofs, H., Castro, M., Sabata, H., Potente, M., Graupera, M., Makinen, T., & Benedito, R. (2024). iSuRe-HadCre is an essential tool for effective conditional genetics. Nucleic Acids Research, 52(13), e56-e56. https://doi.org/10.1093/nar/gkae472
Vancouver
Garcia-Gonzalez I, Rocha SF, Hamidi A, Garcia-Ortega L, Regano A, Sanchez-Muñoz MS, et al. iSuRe-HadCre is an essential tool for effective conditional genetics. Nucleic Acids Research. 2024;52(13):e56-e56. doi:10.1093/nar/gkae472
BibTeX
@article{GarciaGonzalez2024,
author = {Garcia-Gonzalez, Irene and Rocha, Susana F and Hamidi, Anahita and Garcia-Ortega, Lourdes and Regano, Alvaro and Sanchez-Muñoz, Maria S and Lytvyn, Mariya and Garcia-Cabero, Aroa and Roig-Soucase, Sergi and Schoofs, Hans and Castro, Marco and Sabata, Helena and Potente, Michael and Graupera, Mariona and Makinen, Taija and Benedito, Rui},
title = {iSuRe-HadCre is an essential tool for effective conditional genetics},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {13},
pages = {e56--e56},
doi = {10.1093/nar/gkae472}
}
EUVIMED